Regenerative Medicine in the Trump Era Webinar
March 3, 2017
On March 3, 2017, FDA Practice Chair Edward Allera and FDA Shareholder Barbara Binzak Blumenfeld conducted a webinar on Regenerative Medicine in the Trump Era to Kinexum.
One of the few bipartisan results of the decade, passage of the 21st Century Cures Act has put regenerative medicine in the limelight. But, how far, how fast can the intended results of this law be delivered in an era of tremendous upheaval and uncertainty about how healthcare will be financed and managed?